Filing Flows › Generate Biomedicines (GENB) › How it makes money
How Generate Biomedicines (GENB) makes money
Generate Biomedicines (GENB) made $6.3M of revenue in the second quarter 2026 (Q2 2026), -38% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $6.3M | 100.0% |
| Income tax | $53K | 0.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $6.3M | -38% |
| Q1 2026 | $7.2M | -18% |
From Generate Biomedicines' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Generate Biomedicines make money?
Generate Biomedicines (GENB) made $6.3M of revenue in the second quarter 2026 (Q2 2026), -38% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.